スポンサーリンク
Hokkaido University Hospital | 論文
- Ciliates rapidly enhance the frequency of conjugation between Escherichia coli strains through bacterial accumulation in vesicles
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Microdosimetric Evaluation of Secondary Particles in a Phantom Produced by Carbon 290 MeV/nucleon Ions at HIMAC
- SSY-1-2-3 Standard versus Extended Lymph Node Dissection in Pancreatoduodenectomy for Pancreatic Cancer : Japanese multicenter, randomized controlled tria
- Metastatic Breast Cancer of HER2 Scored 2+ by IHC and HER2 Gene Amplification Assayed by FISH Has a Good Response to Single Agent Therapy with Trastuzumab: A Case Report
- MULTICENTER STUDY DESIGN OF THE EX VIVO EVALUATION OF ENDOCYTOSCOPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
- Ten-Year Results of a Randomized Trial on Adjuvant Chemo-Endocrine Therapy with Tamoxifen for Stage II Breast Cancer
- Intratumoral Pyrimidine Nucleoside Phosphorylase (PyNPase) Activity Predicts a Selective Effect of Adjuvant 5'-Deoxy-5-fluorouridine (5' DFUR) on Breast Cancer
- Local Recurrence after Conservative Surgery for Breast Cancer
- Impact of free-living amoebae on presence of Parachlamydia acanthamoebae in the hospital environment and its survival in vitro without requirement for amoebae.
- Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer
- Impact of anaerobic and oligotrophic conditions on survival of Alloiococcus otitidis, implicated as a cause of otitis media
- Host range of obligate intracellular bacterium Parachlamydia acanthamoebae
- Ciliates promote the transfer of the gene encoding the extended-spectrum -lactamase CTX-M-27 between Escherichia coli strains
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Reliability and validity of a new living liver donor quality of life scale